1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
  4. > Rx-OTC Switch Opportunities : Trends in OTC, category analysis, case studies and future opportunities

Summary
After years of buoyant growth, the pharmaceutical industry is facing up to a more challenging time. With the growing cost of developing novel drugs, combined with rising regulatory pressures, the use of lifecycle management is playing an ever-more important role in the increasingly cost-conscious pharma industry. This report identifies actual opportunities in OTC switching.

Key Findings
- The pharmaceutical market is changing. Since 2007, sales of OTC drugs have outstripped those for their prescription counterparts. Whereas once consumer health products were seen as a lucrative sideline, they are becoming a major focus for pharmaceutical companies. Between 2008 and 2013, worldwide OTC growth averaged 6.5% compared to 4.5% for Rx.

- Creating new categories can be fraught with risk. This was shown by the attempts of GSK to introduce the weight-loss therapy area with its Alli (orlistat 60mg capsules). After a promising start, sales collapsed due to concerns over both efficacy and safety.

- With a large and rapidly expanding population, Indonesia is catching the eye of Western multinationals in a number of industries. Within the pharma industry, self-medication is well established and these drugs account for 40% of drug spending.

Synopsis
This report takes an in-depth look at the market for Rx-OTC switches. It considers which categories have the most potential for switching, analyzing both past performance and expected future outcomes, and then examines specific candidates.

Reasons To Buy
- Identify products that have the most Rx-OTC switching potential.

- Analyze the product categories that are changing the Rx-OTC environment.

- Understand why some key Rx-OTC switches have failed.

- Use case studies to assess the revenues generated by successful switches.

Table Of Contents

Rx-OTC Switch Opportunities : Trends in OTC, category analysis, case studies and future opportunities

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
U.S. Insomnia Market by Non-Pharmacological Therapy, Prescription Sleep Aids, Orexin Antagonist & OTC Treatment - Forecasts to 2021

U.S. Insomnia Market by Non-Pharmacological Therapy, Prescription Sleep Aids, Orexin Antagonist & OTC Treatment - Forecasts to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

The U.S. insomnia market is projected to reach USD 4.24 billion by 2021 from USD 3.38 billion in 2016, growing at a CAGR of 4.6% from 2016 to 2021 In 2016, the cognitive behavioural therapy for insomnia ...

Global Over The Counter (OTC) Drugs Market - Segmented by Product Category (Cough, Cold and Flu Products, Analgesics, Dermatological Products, Gastrointestinal Products, Vitamin

Global Over The Counter (OTC) Drugs Market - Segmented by Product Category (Cough, Cold and Flu Products, Analgesics, Dermatological Products, Gastrointestinal Products, Vitamin

  • $ 4250
  • Industry report
  • November 2016
  • by Mordor Intelligence LLP

The global market for over-the-counter (OTC) drugs valued at USD 120 billion and is estimated to scale up to USD 133.25 billion by the end of 2016. Considering the historical trend and possible future ...

Global Over the Counter (OTC) Drugs Market

Global Over the Counter (OTC) Drugs Market

  • $ 4250
  • Industry report
  • December 2016
  • by Mordor Intelligence LLP

The global market for over-the-counter (OTC) drugs valued at USD 120 billion and is estimated to scale up to USD 133.25 billion by the end of 2016. Considering the historical trend and possible future ...

Otc Drugs Markets In China

January 2017 $ 4000

Otc Drugs Companies In China

January 2017 $ 1800

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.